Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (171-180 of 393) with videos related to

Pageof 40
Sort By:
Plos One|April 13, 2011
Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsSatoshi Kurita, Justin L Mott, Sophie C Cazanave, et al.
Molecular Cancer Therapeutics|September 21, 2006
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathwaysChunrong Yu, Bret B Friday, Jin-Ping Lai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Factors associated with increased survival after photodynamic therapy for cholangiocarcinomaGanapathy A Prasad, Kenneth K Wang, Todd H Baron, et al.
American Journal of Cancer Research|December 7, 2023
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.
Journal of Clinical and Translational Hepatology|May 9, 2022
A New Prognostic Model Covering All Stages of Intrahepatic CholangiocarcinomaShuang-Nan Zhou, Shan-Shan Lu, Da-Wei Ju, et al.
Radiology|May 9, 2018
Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT SignalingDanielle E Jondal, Scott M Thompson, Kim A Butters, et al.
American Journal of Cancer Research|April 6, 2019
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.
Plos One|June 16, 2025
Integrative review in PhD admissions: A case study of efficiently minimizing bias while maximizing the student narrativeMinerva A Orellana, Danielle J Beetler, Carmen J Silvano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2016
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United StatesJu Dong Yang, Joseph J Larson, Kymberly D Watt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2022
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort StudyLorena Marcano-Bonilla, Cathy D Schleck, William S Harmsen, et al.
Pageof 40

Showing results (171-180 of 393) with videos related to

Sort By:
Pageof 40
Plos One|April 13, 2011
Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsSatoshi Kurita, Justin L Mott, Sophie C Cazanave, et al.
Molecular Cancer Therapeutics|September 21, 2006
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathwaysChunrong Yu, Bret B Friday, Jin-Ping Lai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Factors associated with increased survival after photodynamic therapy for cholangiocarcinomaGanapathy A Prasad, Kenneth K Wang, Todd H Baron, et al.
American Journal of Cancer Research|December 7, 2023
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.
Journal of Clinical and Translational Hepatology|May 9, 2022
A New Prognostic Model Covering All Stages of Intrahepatic CholangiocarcinomaShuang-Nan Zhou, Shan-Shan Lu, Da-Wei Ju, et al.
Radiology|May 9, 2018
Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT SignalingDanielle E Jondal, Scott M Thompson, Kim A Butters, et al.
American Journal of Cancer Research|April 6, 2019
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.
Plos One|June 16, 2025
Integrative review in PhD admissions: A case study of efficiently minimizing bias while maximizing the student narrativeMinerva A Orellana, Danielle J Beetler, Carmen J Silvano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2016
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United StatesJu Dong Yang, Joseph J Larson, Kymberly D Watt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2022
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort StudyLorena Marcano-Bonilla, Cathy D Schleck, William S Harmsen, et al.
Pageof 40